Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3065 |
|
| Actual shortage: | 231 (8%) | |
| Anticipated shortage: | 16 (1%) | |
| Avoided shortage: | 9 (0%) | |
| Resolved: | 2809 (92%) | |
Discontinuation Reports |
356 |
|
| To be discontinued: | 22 (6%) | |
| Discontinued: | 334 (94%) | |
| Reversed: | 0 (0%) | |
Late reports |
142 (4%) |
|
Overdue reports |
30 (11%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-LEFLUNOMIDE | 20MG | TABLET | Resolved | 2023-05-12 | 2023-06-02 | 192367 |
| APO-INDAPAMIDE 1.25 MG TABLETS | 1.25MG | TABLET | Resolved | 2023-05-12 | 2023-05-26 | 192370 |
| APO-METHYLPHENIDATE | 10MG | TABLET | Resolved | 2023-05-19 | 2023-07-08 | 192785 |
| APO-METOPROLOL | 100MG | TABLET | Resolved | 2023-05-19 | 2023-07-21 | 192791 |
| APO-RISPERIDONE | 2.0MG | TABLET | Resolved | 2023-05-19 | 2023-08-04 | 192803 |
| APO-TRAZODONE D TABLETS 150MG | 150MG | TABLET | Resolved | 2023-05-19 | 2023-10-06 | 192809 |
| APO-ROSUVASTATIN | 40MG | TABLET | Resolved | 2023-05-19 | 2023-06-16 | 192812 |
| APO-ENTECAVIR | 0.5MG | TABLET | Resolved | 2023-05-19 | 2023-06-16 | 192815 |
| APO-RISPERIDONE | 2.0MG | TABLET | Resolved | 2023-05-19 | 2023-08-04 | 192821 |
| APO-ATENOL TAB 50MG | 50MG | TABLET | Resolved | 2023-05-26 | 2023-07-13 | 193203 |
| MYA | 0.02MG 3.00MG | TABLET | Resolved | 2023-05-26 | 2023-06-02 | 193206 |
| APO-TAMOX TAB 10MG | 10MG | TABLET | Resolved | 2023-05-26 | 2023-06-02 | 193209 |
| APO-TERBINAFINE | 250MG | TABLET | Resolved | 2023-05-26 | 2023-06-16 | 193212 |
| APO-NAPRO-NA DS | 550MG | TABLET | Resolved | 2023-05-26 | 2023-07-27 | 193215 |
| APO-TRAZODONE TABLETS 100MG | 100MG | TABLET | Resolved | 2023-05-26 | 2023-07-27 | 193221 |
| APO-VARENICLINE | 0.5MG | TABLET | Resolved | 2023-05-26 | 2023-06-02 | 193227 |
| APO-TETRABENAZINE | 25MG | TABLET | Resolved | 2023-06-02 | 2023-06-23 | 193603 |
| APO-CINACALCET | 60MG | TABLET | Resolved | 2023-06-02 | 2023-06-16 | 193606 |
| APO-PERINDOPRIL/AMLODIPINE | 10MG 14MG | TABLET | Resolved | 2023-06-02 | 2023-06-29 | 193617 |
| APO-BACLOFEN | 10MG | TABLET | Resolved | 2023-06-02 | 2023-08-04 | 193620 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-GLIMEPIRIDE | Discontinued | 2019-09-20 | 2019-09-20 | 94446 | ||
| APO-GLIMEPIRIDE | Discontinued | 2019-09-20 | 2019-09-20 | 94449 | ||
| APO-GLIMEPIRIDE | Discontinued | 2019-09-20 | 2019-09-20 | 94452 | ||
| APO-HYDROCHLOROTHIAZIDE | Discontinued | 2019-11-26 | 2019-11-26 | 99653 | ||
| APO-IMIQUIMOD | Discontinued | 2019-11-26 | 2019-11-26 | 99672 | ||
| APO-CARBAMAZEPINE | Discontinued | 2020-02-19 | 2020-02-19 | 106679 | ||
| APO-NIZATIDINE | 150MG | CAPSULE | Discontinued | 2017-03-13 | 2017-03-13 | 1127 |
| APO-NIZATIDINE | 300MG | CAPSULE | Discontinued | 2017-03-13 | 2017-03-13 | 1135 |
| APO-NORTRIPTYLINE | 10MG | CAPSULE | Discontinued | 2017-03-13 | 2017-03-13 | 1145 |
| APO-NORTRIPTYLINE | 25MG | CAPSULE | Discontinued | 2017-03-13 | 2017-03-13 | 1155 |
| APO-GEMFIBROZIL CAP 300MG USP | 300MG | CAPSULE | Discontinued | 2017-03-31 | 2018-12-07 | 4920 |
| APO-DOCUSATE SODIUM | 100MG | CAPSULE | Discontinued | 2018-02-23 | 2019-03-29 | 40733 |
| DOCUSATE SODIUM CAPSULES | 100MG | CAPSULE | Discontinued | 2018-02-23 | 2018-09-15 | 40738 |
| APO-AMOXI | 250MG | CAPSULE | Discontinued | 2018-09-07 | 2019-02-13 | 60171 |
| APO-AMOXI | 500MG | CAPSULE | Discontinued | 2018-09-07 | 2018-11-09 | 60174 |
| APO-ATOMOXETINE | 60MG | CAPSULE | Discontinued | 2018-09-07 | 2018-09-15 | 60273 |
| APO-CELECOXIB | 100MG | CAPSULE | To be discontinued | 2018-09-07 | 2018-12-11 | 60363 |
| APO-CELECOXIB | 200MG | CAPSULE | Discontinued | 2018-09-07 | 2021-01-21 | 60366 |
| APO-CLINDAMYCIN | 150MG | CAPSULE | To be discontinued | 2018-09-07 | 2018-12-28 | 60396 |
| APO-CLINDAMYCIN | 300MG | CAPSULE | Discontinued | 2018-09-07 | 2019-07-13 | 60399 |